MX2021011848A - Estabilizacion de bacterias mollicutes vivas en una composicion liquida. - Google Patents

Estabilizacion de bacterias mollicutes vivas en una composicion liquida.

Info

Publication number
MX2021011848A
MX2021011848A MX2021011848A MX2021011848A MX2021011848A MX 2021011848 A MX2021011848 A MX 2021011848A MX 2021011848 A MX2021011848 A MX 2021011848A MX 2021011848 A MX2021011848 A MX 2021011848A MX 2021011848 A MX2021011848 A MX 2021011848A
Authority
MX
Mexico
Prior art keywords
live
liquid composition
mollicutes
stabilisation
bacteria
Prior art date
Application number
MX2021011848A
Other languages
English (en)
Inventor
Paul Vermeij
Edwin Kets
Martin Piest
Marian Anna Catharina Jozefina Heijnen
Noël Dautzenberg
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2021011848A publication Critical patent/MX2021011848A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una composición líquida de bacterias Mollicutes vivas y un estabilizador, por los cuales el estabilizador es un disolvente eutéctico profundo natural (NADES). En esta composición líquida, las Mollicutes vivas se estabilizan sin necesidad de congelación o liofilización. Esto permite varios usos ventajosos en diagnósticos y medicina, específicamente como vacuna líquida para usarse contra una infección o enfermedad causada por bacterias Mollicutes, para humanos o animales no humanos.
MX2021011848A 2019-03-29 2020-03-27 Estabilizacion de bacterias mollicutes vivas en una composicion liquida. MX2021011848A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19166362 2019-03-29
PCT/EP2020/058649 WO2020201048A1 (en) 2019-03-29 2020-03-27 Stabilisation of live mollicutes bacteria in a liquid composition

Publications (1)

Publication Number Publication Date
MX2021011848A true MX2021011848A (es) 2021-10-22

Family

ID=66239746

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011848A MX2021011848A (es) 2019-03-29 2020-03-27 Estabilizacion de bacterias mollicutes vivas en una composicion liquida.

Country Status (8)

Country Link
US (1) US20220175902A1 (es)
EP (1) EP3946442A1 (es)
JP (1) JP2022526542A (es)
CN (1) CN113645997A (es)
AR (1) AR118519A1 (es)
BR (1) BR112021018854A2 (es)
MX (1) MX2021011848A (es)
WO (1) WO2020201048A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR127944A1 (es) 2021-12-23 2024-03-13 Intervet Int Bv Vacunas líquidas estabilizadas de virus vivos
CN114806972B (zh) * 2022-06-07 2023-12-08 中国海洋大学 一种利用天然低共熔溶剂制备高活性乳酸菌发酵剂的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8247198B2 (en) 2007-09-21 2012-08-21 Friedrich Srienc Enzymatic processing in deep eutectic solvents
US8022014B2 (en) 2008-03-26 2011-09-20 Shrieve Chemical Products, Inc. Deep eutectic solvents and applications
NL2004835C2 (en) 2010-06-07 2011-12-08 Univ Leiden Process for extracting materials from biological material.
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
GB201303666D0 (en) 2013-03-01 2013-04-17 Goldsborough Andrew S Sample fixation and stabilisation
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
WO2016108083A1 (en) 2014-12-31 2016-07-07 University Of Oslo Eutectic solvents and uses thereof
FR3034625A1 (fr) 2015-04-10 2016-10-14 Naturex Solvant eutectique d'extraction, procede d'extraction par eutectigenese utilisant ledit solvant, et extrait issu dudit procede d'extraction.
CN109843078A (zh) 2016-06-24 2019-06-04 百士立丰有限公司 用于提供在加热下不会变干的可消耗和可消化的水源的方法
AR113996A1 (es) 2017-12-22 2020-07-08 Intervet Int Bv Vacunas líquidas de virus envueltos vivos

Also Published As

Publication number Publication date
CN113645997A (zh) 2021-11-12
WO2020201048A1 (en) 2020-10-08
JP2022526542A (ja) 2022-05-25
BR112021018854A2 (pt) 2021-11-30
EP3946442A1 (en) 2022-02-09
US20220175902A1 (en) 2022-06-09
AR118519A1 (es) 2021-10-20

Similar Documents

Publication Publication Date Title
MX2017014488A (es) Composiciones para transplante de la flora fecal y metodos para elaborarlos y utilizarlos y dispositivos para suministrarlos.
CL2017002928A1 (es) Composiciones de inoculante microbiano y sus usos en la agricultura
MX2021011848A (es) Estabilizacion de bacterias mollicutes vivas en una composicion liquida.
CL2017000895A1 (es) Proteínas quiméricas insecticidas novedosas tóxicas o inhibidores de plagas de lepidópteros.
EA201790294A1 (ru) Средства на основе флагеллина и применения, включающие эффективную вакцинацию
EA201691766A1 (ru) Органические соединения, являющиеся монобактамами, для лечения бактериальных инфекций
EA201791353A1 (ru) СОЕДИНЕНИЯ ИЗОКСАЗОЛГИДРОКСАМИНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LpxC
PH12017500708A1 (en) Probiotic and prebiotic compositions
EA201890314A3 (ru) Композиции, содержащие липохитоолигосахарид и микроорганизм для усиления роста растения
PH12016502003A1 (en) Novel bacteriophage and composition containing same
EA201691804A1 (ru) Быстродействующие штаммы lactobacillus и их применение для улучшения аэробной стабильности силоса
EA201991798A1 (ru) Стабильные при хранении составы
EA201990551A1 (ru) Антибиотические соединения
EA202090500A1 (ru) Кристаллические формы иммуномодуляторов
TR201904336T4 (tr) Dökme, damlatma uygulaması, daldırma uygulaması veya toprak enjeksiyonu vasıtasıyla kırmızı örümcekler ile mücadeleye yönelik N-arilamidin ile sübstitüe edilen trifloroetilsülfoksit türevlerinin kullanımı.
GB2539148A (en) Vaccine compositions
PH12016502001B1 (en) Novel bacteriophage and composition comprising same
MX2017012073A (es) Compuestos de minociclina para biodefensas.
PH12020550426A1 (en) Active compound combinations having insecticidal/acaricidal properties
PH12020550425A1 (en) Active compound combinations having insecticidal/acaricidal properties
EA202091118A1 (ru) Антибактериальные соединения
ZA202002832B (en) Active compound combinations having insecticidal/acaricidal properties
GT201300182A (es) Metodo para el tratamiento de una infeccion
EA201591583A1 (ru) Ветеринарная композиция для накожного применения
PH12020550428A1 (en) Active compound combinations having insecticidal/acaricidal properties